BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5346476)

  • 1. The sensitivity of a Yoshida sarcoma to methylene dimethane sulphonate.
    Fox BW
    Int J Cancer; 1969 Jan; 4(1):54-60. PubMed ID: 5346476
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigations on the mechanism of action of cytotoxic hexitols. I. Cross-resistance investigations on Yoshida sarcoma tumour.
    Jeney A; Szabó J; Vályi-Nagy T
    Neoplasma; 1968; 15(3):231-5. PubMed ID: 5667085
    [No Abstract]   [Full Text] [Related]  

  • 3. The establishment of cloned cell lines from Yoshida sarcomas having differential sensitivities to methylene dimethane sulphonate in vivo and their cross-sensitivity to x-rays, UV and other alkylating agents.
    Fox M; Fox BW
    Chem Biol Interact; 1972 Apr; 4(5):363-75. PubMed ID: 5009846
    [No Abstract]   [Full Text] [Related]  

  • 4. The nature of the resistance to methylene dimethane sulphonate in the Yoshida sarcoma.
    Fox BW; Fox M
    Br J Cancer; 1973 Jul; 28(1):81. PubMed ID: 4737505
    [No Abstract]   [Full Text] [Related]  

  • 5. The selectivity of action of alkylating agents and drug resistance. II. A comparison of the effects of alkylating drugs on growth inhibition and cell size in sensitive and resistant strains of the Yoshida ascites sarcoma.
    Harrap KR; Hill BT
    Br J Cancer; 1969 Mar; 23(1):227-34. PubMed ID: 5768439
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of the immunosuppressive activity of methylene dimethane sulphonate (MDMS) in relation to its effectiveness as an anti-tumour agent.
    Fox BW; Gregory CJ
    Br J Cancer; 1972 Apr; 26(2):84-9. PubMed ID: 5064536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selectivity of action of alkylating agents and drug resistance. I. Biochemical changes occurring in sensitive and resistant strains of the Yoshida ascites sarcoma following chemotherapy.
    Harrap KR; Hill BT
    Br J Cancer; 1969 Mar; 23(1):210-26. PubMed ID: 5768437
    [No Abstract]   [Full Text] [Related]  

  • 8. Cathepsins inhibit growth of Yoshida ascites sarcoma in rat.
    Allegretti N; Andreis I; Kopitar M; Lebez D
    Nat New Biol; 1971 Feb; 229(6):180-1. PubMed ID: 4102010
    [No Abstract]   [Full Text] [Related]  

  • 9. The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma.
    Miko M; Ujházy V
    Neoplasma; 1968; 15(4):357-63. PubMed ID: 5684461
    [No Abstract]   [Full Text] [Related]  

  • 10. Identical karyotypes in acquired drug-resistant sublines of Yoshida sarcoma.
    Ujhåzy V
    Neoplasma; 1974; 21(6):665-9. PubMed ID: 4444746
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on two variant strains of Yoshida sarcoma characterized by island formation in ascites.
    Ishidate M; Isaka H
    Gan; 1966 Aug; 57(4):413-26. PubMed ID: 5338890
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE INFLUENCE OF PRELIMINARY TREATMENT OF RATS WITH ALKYLATING SUBSTANCES AND OTHER TOXINS ON THE GROWTH OF YOSHIDA SARCOMA].
    SCHMAEHL D; SATTLER W
    Arzneimittelforschung; 1964 Jul; 14():746-50. PubMed ID: 14344711
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study about the growth of two tumors of the solid Yoshida sarcoma of the rat in the same animals as well as about the reactions of tumors of different sizes to treatment with 2-, 3-, 5-trisethyleneiminobenzochinone (1,4) (author's transl)].
    Hartleib J
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974 Mar; 81(1):1-6. PubMed ID: 4275054
    [No Abstract]   [Full Text] [Related]  

  • 14. Collateral sensitivity between methylene dimethane sulfonate and halogenated methotrexate derivatives in the Yoshida sarcoma in vivo and in vitro.
    Fox BW
    J Natl Cancer Inst; 1977 Apr; 58(4):955-8. PubMed ID: 191629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STUDIES ON ACQUIRED TRANSPLANTATION RESISTANCE. I. PRETREATMENT OF DONRYU RAT WITH ATTENUATED YOSHIDA SARCOMA CELLS.
    ISHIDATE M; HASHIMOTO Y; ODASHIMA S; SUDO H
    Gan; 1965 Feb; 56():13-21. PubMed ID: 14326030
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the study of the implantation of ascites tumor in urinary bladder. IV. Effect of antitumor agents (1)].
    Suzuki K; Sugita A; Miura T; Kato M; Onodera Y
    Nihon Hinyokika Gakkai Zasshi; 1967 Oct; 58(10):1003-9. PubMed ID: 4296284
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological response of adoptive transfer for the growth of Yoshida sarcoma.
    Ishikawa Y; Fukushima M; Sato T; Komaba M; Kakuta H
    Gan; 1968 Dec; 59(6):453-60. PubMed ID: 5721580
    [No Abstract]   [Full Text] [Related]  

  • 18. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental animal model on postoperative tumor recurrence prophylaxis with cytostatic agents].
    Kallenbach H; Schuster R
    Langenbecks Arch Chir; 1966; 316():521-5. PubMed ID: 5979724
    [No Abstract]   [Full Text] [Related]  

  • 20. The cytotoxic effect of plasmin on Yoshida sarcoma cells.
    Hilgard P; Hiemeyer V
    Rev Fr Etud Clin Biol; 1969 Nov; 14(9):902-4. PubMed ID: 4243799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.